|
The world's first pharmacogenetic microarray-based test approved for clinical use.
The AmpliChip CYP450 Test provides comprehensive coverage of gene variations - including deletions and duplications - for
the CYP2D6 and CYP2C19 genes, which play a major role in the metabolism of an estimated 25% of all prescription drugs. It is
intended to be an aid for physicians in individualizing treatment selection and dosing for drugs metabolized through these
genes. |